| Literature DB >> 30979779 |
Saška Ivanova1,2,3, Mira Polajnar4,5,6, Alvaro Jesus Narbona-Perez7, Maria Isabel Hernandez-Alvarez7,3,8, Petra Frager7, Konstantin Slobodnyuk7, Natalia Plana7, Angel R Nebreda7,9, Manuel Palacin7,2,10, Roger R Gomis7,9,11,12, Christian Behrends4,6, Antonio Zorzano1,2,3.
Abstract
TP53INP2 positively regulates autophagy by binding to Atg8 proteins. Here, we uncover a novel role of TP53INP2 in death-receptor signaling. TP53INP2 sensitizes cells to apoptosis induced by death receptor ligands. In keeping with this, TP53INP2 deficiency in cultured cells or mouse livers protects against death receptor-induced apoptosis. TP53INP2 binds caspase-8 and the ubiquitin ligase TRAF6, thereby promoting the ubiquitination and activation of caspase-8 by TRAF6. We have defined a TRAF6-interacting motif (TIM) and a ubiquitin-interacting motif in TP53INP2, enabling it to function as a scaffold bridging already ubiquitinated caspase-8 to TRAF6 for further polyubiquitination of caspase-8. Mutations of key TIM residues in TP53INP2 abrogate its interaction with TRAF6 and caspase-8, and subsequently reduce levels of death receptor-induced apoptosis. A screen of cancer cell lines showed that those with higher protein levels of TP53INP2 are more prone to TRAIL-induced apoptosis, making TP53INP2 a potential predictive marker of cancer cell responsiveness to TRAIL treatment. These findings uncover a novel mechanism for the regulation of caspase-8 ubiquitination and reveal TP53INP2 as an important regulator of the death receptor pathway.Entities:
Keywords: TP53INP2; TRAF6; apoptosis; death receptor signaling; ubiquitination
Mesh:
Substances:
Year: 2019 PMID: 30979779 PMCID: PMC6518029 DOI: 10.15252/embj.201899300
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598